Raffi Asadorian
2016 - Amyris
In 2016, Raffi Asadorian earned a total compensation of $614.4K as Chief Financial Officer at Amyris, a 51% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $28,519 |
---|---|
Option Awards | $76,400 |
Salary | $450,000 |
Stock Awards | $59,000 |
Other | $468 |
Total | $614,387 |
Asadorian received $450K in salary, accounting for 73% of the total pay in 2016.
Asadorian also received $28.5K in non-equity incentive plan, $76.4K in option awards, $59K in stock awards and $468 in other compensation.
Rankings
In 2016, Raffi Asadorian's compensation ranked 10,446th out of 14,075 executives tracked by ExecPay. In other words, Asadorian earned more than 25.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,446 | 26th |
Manufacturing | 4,034 | 27th |
Chemicals And Allied Products | 1,426 | 25th |
Industrial Organic Chemicals | 50 | 31st |
Asadorian's colleagues
We found three more compensation records of executives who worked with Raffi Asadorian at Amyris in 2016.
News
AcelRx Pharmaceuticals CEO Vincent Angotti's 2023 pay slips 7% to $1.2M
April 29, 2024
AcelRx Pharmaceuticals CEO Vincent Angotti's 2022 pay falls 47% to $1.3M
August 28, 2023
AcelRx Pharmaceuticals CEO Vincent Angotti's 2021 pay jumps 39% to $2.4M
June 3, 2022
AcelRx Pharmaceuticals CEO Vincent Angotti's 2019 pay jumps 22% to $2.1M
April 24, 2020
AcelRx Pharmaceuticals CEO Vincent Angotti's 2018 pay falls 26% to $1.7M
May 14, 2019